Roche touts industry-first liver cancer win, expects more Tecentriq adjuvant data this year aliu Thu, 01/19/2023 – 09:17 More: Roche touts industry-first liver cancer win, expects more Tecentriq adjuvant data this year Source: fierce
read moreTherapy is among the first to receive a positive draft recommendation under streamlined pilot process More: Amvuttra recommended by NICE for amyloidosis Source: News
read moreThe new funding package will be used to progress NeoPhore’s expanding pipeline of therapies More: NeoPhore gains additional financing for discovery pipeline Source: News
read moreServier, Taiho score in phase 3 colorectal cancer trial to support Lonsurf combo nod kdunleavy Wed, 01/18/2023 – 15:13 More: Servier, Taiho score in phase 3 colorectal cancer trial to support Lonsurf combo nod Source: fierce
read moreAbbVie, Novartis and more win national coverage in China even as Pfizer’s Paxlovid gets left out aliu Wed, 01/18/2023 – 14:00 More: AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid gets left out Source: fierce
read moreCharles River inks gene therapy development and manufacturing pact with South Korean biopharma jkeenan Wed, 01/18/2023 – 13:36 More: Charles River inks gene therapy development and manufacturing pact with South Korean biopharma Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals